Showing results 1 - 10 of 17
March 2025, Paper: "We measure whether expert patients – those trained as physicians and nurses – have fewer emergency department visits and the reasons for these differences.…
November 27, 2024, Paper: "The sole orphan exemption will exclude billions of dollars of Medicare drug spending from price negotiation. The high level of global revenues achieved…
October 2024, Paper: "Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates…
2024, Paper: "Recent efforts to control spending, including accountable care organizations, value-based payment, and high-deductible health plans, have emphasized optimizing…
August 2024, Paper: "Research and development (R&D) investment in the biopharmaceutical industry drives the discovery of new drugs to address unmet medical needs and improve…
June 13, 2024, Paper: "Recent efforts to control spending, including accountable care organizations, value-based payment, and high-deductible health plans, have emphasized…
February 2024, Paper: "Biotech innovations lead to the development of life-saving drugs and vaccines. However, bringing a new drug to market is an expensive, risky, and time-…
February 8, 2024, Paper: "The growth in spending on health care has over the last decade, easing fears that…
January 5, 2024, Video: "In the fourth episode of…
December 4, 2023, Paper: "Notwithstanding concerns about staffing levels and burnout in health care, federal wage and employment data does not support the suggestion that a Covid-…